Treatment and delay of outset of synucleinopathic and amyloidogenic disease Grant US-9034337-B2 United States of America 19 May 2015
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant US-8697082-B2 United States of America 15 Apr 2014
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant US-8506959-B2 United States of America 13 Aug 2013
Prevention and treatment of amyloidgenic disease Grant US-7964192-B1 United States of America 21 Jun 2011
Treatment and delay of outset of Parkinson's disease Grant US-7727957-B2 United States of America 01 Jun 2010
Humanized antibodies that recognize beta amyloid peptide Grant US-7189819-B2 United States of America 13 Mar 2007
Humanized antibodies that recognize beta amyloid peptide Grant US-7179892-B2 United States of America 20 Feb 2007
Active immunization of AScr for prion disorders Grant US-6923964-B1 United States of America 02 Aug 2005
Pharmaceutical compositions and methods for treatment of amyloid diseases Grant US-6890535-B1 United States of America 10 May 2005
Prevention and treatment of amyloidogenic disease Grant US-6787143-B1 United States of America 07 Sep 2004
Prevention and treatment of amyloidogenic disease Grant US-6787138-B1 United States of America 07 Sep 2004
Prevention and treatment of amyloidogenic disease Grant US-6787523-B1 United States of America 07 Sep 2004
Prevention and treatment of amyloidogenic disease Grant US-6787140-B1 United States of America 07 Sep 2004
Prevention and treatment of amyloidogenic disease Grant US-6787144-B1 United States of America 07 Sep 2004
Prevention and treatment of amyloidogenic disease Grant US-6787139-B1 United States of America 07 Sep 2004
Passive immunization treatment of Alzheimer's disease Grant US-6761888-B1 United States of America 13 Jul 2004
Humanized and chimeric N-terminal amyloid beta-antibodies Grant US-6750324-B1 United States of America 15 Jun 2004
Prevention and treatment of amyloidogenic disease Grant US-6743427-B1 United States of America 01 Jun 2004
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on… Grant US-6710226-B1 United States of America 23 Mar 2004